Philips is the manufacturer of numerous sleep and respiratory care products, including the Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices.
On June 30, 2021 Philips issued a voluntary recall on several of its respiratory devices due to concerns of a link between the polyester-based polyurethane (PE-PUR) sound abatement foam used in the products and potential health risks to its users. The PE-PUR foam poses a threat if it degrades into particles that can be suspended in the air within the device and then inhaled by the user.
Additionally, the PE-PUR foam may “off-gas” specific chemicals. Inhalation of these chemicals can be life-threatening, cause permanent impairment, or require medical intervention to prevent permanent impairment.
The recall includes the following product lines:
- Trilogy 100
- Trilogy 200
- Garbin Plus
- BiPAP V30
- BiPAP A30/A40 Series Device Models
Potential risks of exposure to foam particles include: severe irritation (skin, eye, and respiratory tract), inflammatory response, headache, asthma, adverse effects to other organs (e.g. kidneys and liver) and toxic carcinogenic effects.
Potential risks of chemical exposure from off-gassing include: headache/dizziness, irritation (eyes, nose, respiratory tract, skin), hypersensitivity, nausea/vomiting, toxic and carcinogenic effects. There have been no reported deaths related to these issues thus far.
Please do not hesitate to contact our office if you or a loved one have used a Philips device listed above and are suffering from any of the following conditions:
- Cancer of the Pulmonary System (e.g. nose, nasal passages, pharynx, larynx, trachea and lungs)
- Suspicion of Cancer/Cancer Monitoring
- Severe Respiratory Burning or Inflammation
- Chemical-Induced Nausea and Vomiting
Please contact Slater Slater Schulman LLP at 1-800-251-6990 or fill out our online form and an attorney will contact you shortly.